Ocriplasmin
Indication
Vitreomacular traction (NICE TA297)
NICE TA297 - Ocriplasmin for treating vitreomacular traction
Red
Brand:
JETREA®
Nice TA:
297
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Eye
Background
Ocriplasmin is recommended as a possible treatment for adults with an eye condition called vitreomacular traction who also have:
-
no epi-retinal membrane (a thin layer of scar tissue over their retina, the light-sensitive area at the back of the eye) and
-
a hole (up to 400 micrometers) in the centre of their retina or
-
severe sight problems.